Germany
Japan
United Kingdom
China
Recombinant Anti-CCRL2 (Clone BZ5B8)
| Applications | ELISA, FC, FN, ICC, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Primary Antibodies
View as table DownloadRecombinant Anti-CCRL2 (Clone BZ2E3)
| Applications | ELISA, FC, FN, ICC, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Recombinant Anti-CMKLR1 (Clone BZ194)
| Applications | ELISA, FC, FN, IF, IHC, IP, WB |
| Reactivities | Mouse |
| Conjugation | Unconjugated |
Fluorescein (FITC) Monoclonal Antibody
| Applications | ELISA, FC, IHC, WB |
| Conjugation | Unconjugated |
Fluorescein (FITC) Monoclonal Antibody
| Applications | ELISA, FC, IHC, WB |
| Conjugation | Unconjugated |
Fluorescein (FITC) Monoclonal Antibody
| Applications | ELISA, FC, IHC, WB |
| Conjugation | Unconjugated |
DYKDDDDK Antibody same epitope as Sigma's Anti-FLAG
| Applications | ELISA, FC, IHC, WB |
| Conjugation | Unconjugated |
AKT1 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
AKT1 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
AKT2 Antibody
| Applications | ELISA, FC, IHC, WB |
| Reactivities | Human |
| Conjugation | Unconjugated |
Mouse anti double-stranded RNA (J2)
| Applications | Dot, dsRNA-immunoblotting, ELISA, FC, ICC, IHC, Immuno-affinity-chromatography |
| Conjugation | Unconjugated |
Active filters
Applications
- ELISA
Isotypes
- IgG2a, kappa
Assay Types
- Indirect
Filter by
Category
Target Symbol
- AKT2 (5)
- CALCA (4)
- AKT1 (2)
- BIRC5 (2)
- CCRL2 (2)
- DSRED (2)
- ITGB2 (2)
- LAG3 (2)
- TNF (2)
- ALKALINE PHOSPHATASE (1)
- AOC3 (1)
- APP (1)
- C-MYC (1)
- C5AR1 (1)
- CCR5 (1)
- CD28 (1)
- CD3E (1)
- CD44 (1)
- CMKLR1 (1)
- DNTT (1)
- EPCAM (1)
- ERBB2 (1)
- ESRP2 (1)
- F (1)
- GROUP ANTIGEN (1)
- H4 (1)
- IGF2R (1)
- IL16 (1)
- IL17A (1)
- IL27 (1)
- IL5 (1)
- IL7R (1)
- INSR (1)
- ITGA2B (1)
- KRT20 (1)
- MSLN (1)
- MUC1 (1)
- MYOD1 (1)
- PVR (1)
- RELA (1)
- STAT2 (1)
- TGFA (1)
- TP53 (1)
- TYRP1 (1)
- VEGFA (1)
Reactivities
Antibody Hosts
Clonalities
Conjugates
Recombinant
Biosimilar
Families
- Druggable Genome (4)
- Stem cell - Pluripotency (3)
- Embryonic stem cells (1)
- Induced pluripotent stem cells (1)
- Stem cell relevant signaling - JAK/STAT signaling pathway (1)
- Stem cell relevant signaling - TGFb/BMP signaling pathway (1)
- Stem cell relevant signaling - Wnt Signaling pathway (1)
- Transcription Factors (1)
- Transmembrane (1)
Pathways
- Colorectal cancer (3)
- Pathways in cancer (3)
- Acute myeloid leukemia (1)
- Bladder cancer (1)
- Cell cycle (1)
- Chronic myeloid leukemia (1)
- Endometrial cancer (1)
- ErbB signaling pathway (1)
- Folate biosynthesis (1)
- Jak-STAT signaling pathway (1)
- Lysosome (1)
- MAPK signaling pathway (1)
- Metabolic pathways (1)
- Small cell lung cancer (1)
- TGF-beta signaling pathway (1)
- Thyroid cancer (1)
- Wnt signaling pathway (1)